Semiconductors
Compare Stocks
3 / 10Stock Comparison
ACMR vs ICHR vs UCTT
Revenue, margins, valuation, and 5-year total return — side by side.
Semiconductors
Semiconductors
ACMR vs ICHR vs UCTT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||
|---|---|---|---|
| Industry | Semiconductors | Semiconductors | Semiconductors |
| Market Cap | $3.67B | $2.52B | $3.80B |
| Revenue (TTM) | $901M | $959M | $2.07B |
| Net Income (TTM) | $94M | $-51M | $-194M |
| Gross Margin | 44.4% | 11.3% | 15.6% |
| Operating Margin | 12.1% | -3.8% | -5.3% |
| Forward P/E | 27.8x | 63.4x | 36.0x |
| Total Debt | $303M | $186M | $810M |
| Cash & Equiv. | $766M | $98M | $312M |
ACMR vs ICHR vs UCTT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| ACM Research, Inc. (ACMR) | 100 | 277.9 | +177.9% |
| Ichor Holdings, Ltd. (ICHR) | 100 | 318.7 | +218.7% |
| Ultra Clean Holding… (UCTT) | 100 | 402.6 | +302.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ACMR vs ICHR vs UCTT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ACMR carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 3 yrs, beta 3.24, yield 0.2%
- Rev growth 15.2%, EPS growth -10.5%, 3Y rev CAGR 32.3%
- 28.6% 10Y total return vs UCTT's 14.5%
ICHR is the clearest fit if your priority is momentum.
- +353.2% vs ACMR's +182.8%
UCTT is the clearest fit if your priority is defensive.
- Beta 3.19, current ratio 3.19x
- Beta 3.19 vs ICHR's 3.93
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 15.2% revenue growth vs UCTT's -2.1% | |
| Value | Lower P/E (27.8x vs 36.0x) | |
| Quality / Margins | 10.4% margin vs UCTT's -9.4% | |
| Stability / Safety | Beta 3.19 vs ICHR's 3.93 | |
| Dividends | 0.2% yield; 3-year raise streak; the other 2 pay no meaningful dividend | |
| Momentum (1Y) | +353.2% vs ACMR's +182.8% | |
| Efficiency (ROA) | 3.9% ROA vs UCTT's -11.0%, ROIC 7.0% vs 2.6% |
ACMR vs ICHR vs UCTT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
ACMR vs ICHR vs UCTT — Financial Metrics
Side-by-side numbers across 3 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
ACMR leads in 5 of 6 categories
ICHR leads 0 • UCTT leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
ACMR leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
UCTT is the larger business by revenue, generating $2.1B annually — 2.3x ACMR's $901M. ACMR is the more profitable business, keeping 10.4% of every revenue dollar as net income compared to UCTT's -9.4%. On growth, ACMR holds the edge at +9.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||
|---|---|---|---|
| RevenueTrailing 12 months | $901M | $959M | $2.1B |
| EBITDAEarnings before interest/tax | $126M | -$11M | -$52M |
| Net IncomeAfter-tax profit | $94M | -$51M | -$194M |
| Free Cash FlowCash after capex | -$69M | -$17M | -$44M |
| Gross MarginGross profit ÷ Revenue | +44.4% | +11.3% | +15.6% |
| Operating MarginEBIT ÷ Revenue | +12.1% | -3.8% | -5.3% |
| Net MarginNet income ÷ Revenue | +10.4% | -5.3% | -9.4% |
| FCF MarginFCF ÷ Revenue | -7.6% | -1.7% | -2.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | +9.4% | +4.7% | +2.9% |
| EPS Growth (YoY)Latest quarter vs prior year | -76.1% | +46.2% | -2.6% |
Valuation Metrics
ACMR leads this category, winning 3 of 5 comparable metrics.
Valuation Metrics
On an enterprise value basis, ACMR's 25.5x EV/EBITDA is more attractive than UCTT's 35.9x.
| Metric | |||
|---|---|---|---|
| Market CapShares × price | $3.7B | $2.5B | $3.8B |
| Enterprise ValueMkt cap + debt − cash | $3.2B | $2.6B | $4.3B |
| Trailing P/EPrice ÷ TTM EPS | 40.42x | -47.08x | -20.86x |
| Forward P/EPrice ÷ next-FY EPS est. | 27.77x | 63.37x | 35.97x |
| PEG RatioP/E ÷ EPS growth rate | 1.14x | — | — |
| EV / EBITDAEnterprise value multiple | 25.48x | — | 35.88x |
| Price / SalesMarket cap ÷ Revenue | 4.07x | 2.66x | 1.85x |
| Price / BookPrice ÷ Book value/share | 1.93x | 3.74x | 4.82x |
| Price / FCFMarket cap ÷ FCF | — | — | 258.27x |
Profitability & Efficiency
ACMR leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
ACMR delivers a 6.1% return on equity — every $100 of shareholder capital generates $6 in annual profit, vs $-25 for UCTT. ACMR carries lower financial leverage with a 0.16x debt-to-equity ratio, signaling a more conservative balance sheet compared to UCTT's 1.03x. On the Piotroski fundamental quality scale (0–9), UCTT scores 5/9 vs ACMR's 2/9, reflecting solid financial health.
| Metric | |||
|---|---|---|---|
| ROE (TTM)Return on equity | +6.1% | -7.5% | -25.4% |
| ROA (TTM)Return on assets | +3.9% | -5.2% | -11.0% |
| ROICReturn on invested capital | +7.0% | -3.9% | +2.6% |
| ROCEReturn on capital employed | +6.6% | -4.7% | +2.9% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 3 | 5 |
| Debt / EquityFinancial leverage | 0.16x | 0.28x | 1.03x |
| Net DebtTotal debt minus cash | -$463M | $87M | $499M |
| Cash & Equiv.Liquid assets | $766M | $98M | $312M |
| Total DebtShort + long-term debt | $303M | $186M | $810M |
| Interest CoverageEBIT ÷ Interest expense | 20.44x | -5.97x | -5.80x |
Total Returns (Dividends Reinvested)
ACMR leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ACMR five years ago would be worth $22,064 today (with dividends reinvested), compared to $13,383 for ICHR. Over the past 12 months, ICHR leads with a +353.2% total return vs ACMR's +182.8%. The 3-year compound annual growth rate (CAGR) favors ACMR at 76.5% vs ICHR's 36.7% — a key indicator of consistent wealth creation.
| Metric | |||
|---|---|---|---|
| YTD ReturnYear-to-date | +23.4% | +255.3% | +205.5% |
| 1-Year ReturnPast 12 months | +182.8% | +353.2% | +334.0% |
| 3-Year ReturnCumulative with dividends | +450.0% | +155.6% | +200.3% |
| 5-Year ReturnCumulative with dividends | +120.6% | +33.8% | +73.6% |
| 10-Year ReturnCumulative with dividends | +2861.5% | +642.2% | +1451.3% |
| CAGR (3Y)Annualised 3-year return | +76.5% | +36.7% | +44.3% |
Risk & Volatility
Evenly matched — ICHR and UCTT each lead in 1 of 2 comparable metrics.
Risk & Volatility
UCTT is the less volatile stock with a 3.19 beta — it tends to amplify market swings less than ICHR's 3.93 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ICHR currently trades 99.5% from its 52-week high vs ACMR's 77.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||
|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 3.24x | 3.93x | 3.19x |
| 52-Week HighHighest price in past year | $71.65 | $72.87 | $87.68 |
| 52-Week LowLowest price in past year | $19.10 | $13.12 | $18.52 |
| % of 52W HighCurrent price vs 52-week peak | +77.3% | +99.5% | +95.2% |
| RSI (14)Momentum oscillator 0–100 | 56.2 | 61.4 | 62.0 |
| Avg Volume (50D)Average daily shares traded | 1.2M | 795K | 1.3M |
Analyst Outlook
ACMR leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: ACMR as "Buy", ICHR as "Buy", UCTT as "Buy". Consensus price targets imply 1.8% upside for UCTT (target: $85) vs -31.3% for ICHR (target: $50). ACMR is the only dividend payer here at 0.20% yield — a key consideration for income-focused portfolios.
| Metric | |||
|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $40.00 | $49.80 | $85.00 |
| # AnalystsCovering analysts | 10 | 14 | 12 |
| Dividend YieldAnnual dividend ÷ price | +0.2% | — | — |
| Dividend StreakConsecutive years of raises | 3 | 1 | 1 |
| Dividend / ShareAnnual DPS | $0.11 | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +0.2% | 0.0% | +0.1% |
ACMR leads in 5 of 6 categories — strongest in Income & Cash Flow and Valuation Metrics. 1 category is tied.
ACMR vs ICHR vs UCTT: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is ACMR or ICHR or UCTT a better buy right now?
For growth investors, ACM Research, Inc.
(ACMR) is the stronger pick with 15. 2% revenue growth year-over-year, versus -2. 1% for Ultra Clean Holdings, Inc. (UCTT). ACM Research, Inc. (ACMR) offers the better valuation at 40. 4x trailing P/E (27. 8x forward), making it the more compelling value choice. Analysts rate ACM Research, Inc. (ACMR) a "Buy" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ACMR or ICHR or UCTT?
On forward P/E, ACM Research, Inc.
is actually cheaper at 27. 8x.
03Which is the better long-term investment — ACMR or ICHR or UCTT?
Over the past 5 years, ACM Research, Inc.
(ACMR) delivered a total return of +120. 6%, compared to +33. 8% for Ichor Holdings, Ltd. (ICHR). Over 10 years, the gap is even starker: ACMR returned +28. 6% versus ICHR's +642. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ACMR or ICHR or UCTT?
By beta (market sensitivity over 5 years), Ultra Clean Holdings, Inc.
(UCTT) is the lower-risk stock at 3. 19β versus Ichor Holdings, Ltd. 's 3. 93β — meaning ICHR is approximately 23% more volatile than UCTT relative to the S&P 500. On balance sheet safety, ACM Research, Inc. (ACMR) carries a lower debt/equity ratio of 16% versus 103% for Ultra Clean Holdings, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — ACMR or ICHR or UCTT?
By revenue growth (latest reported year), ACM Research, Inc.
(ACMR) is pulling ahead at 15. 2% versus -2. 1% for Ultra Clean Holdings, Inc. (UCTT). On earnings-per-share growth, the picture is similar: ACM Research, Inc. grew EPS -10. 5% year-over-year, compared to -869. 2% for Ultra Clean Holdings, Inc.. Over a 3-year CAGR, ACMR leads at 32. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ACMR or ICHR or UCTT?
ACM Research, Inc.
(ACMR) is the more profitable company, earning 10. 4% net margin versus -8. 8% for Ultra Clean Holdings, Inc. — meaning it keeps 10. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ACMR leads at 12. 1% versus -4. 1% for ICHR. At the gross margin level — before operating expenses — ACMR leads at 44. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is ACMR or ICHR or UCTT more undervalued right now?
On forward earnings alone, ACM Research, Inc.
(ACMR) trades at 27. 8x forward P/E versus 63. 4x for Ichor Holdings, Ltd. — 35. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for UCTT: 1. 8% to $85. 00.
08Which pays a better dividend — ACMR or ICHR or UCTT?
In this comparison, ACMR (0.
2% yield) pays a dividend. ICHR, UCTT do not pay a meaningful dividend and should not be held primarily for income.
09Is ACMR or ICHR or UCTT better for a retirement portfolio?
For long-horizon retirement investors, Ultra Clean Holdings, Inc.
(UCTT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+1451% 10Y return). ACM Research, Inc. (ACMR) carries a higher beta of 3. 24 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (UCTT: +1451%, ACMR: +28. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between ACMR and ICHR and UCTT?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: ACMR is a small-cap high-growth stock; ICHR is a small-cap quality compounder stock; UCTT is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.